
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 March 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 220 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Statin use and risk of glioma: population-based case-control analysis”, Eur J Epidemiol, vol. 31, pp. 947-52, 2016.
, “Statins and newly diagnosed diabetes”, Br J Clin Pharmacol, vol. 58, pp. 303-9, 2004.
, “Statins and the risk of dementia”, Lancet, vol. 356, pp. 1627-31, 2000.
, “Statins and the risk of idiopathic venous thromboembolism”, Br J Clin Pharmacol, vol. 53, pp. 101-5, 2002.
, “Statins and the risk of pneumonia: a population-based, nested case-control study”, Pharmacotherapy, vol. 27, pp. 325-32, 2007.
, “Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study”, Drug Saf, vol. 42, pp. 55-66, 2019.
, “A study of the relation of exposure to quinolones and suicidal behaviour”, Br J Clin Pharmacol, vol. 45, pp. 77-81, 1998.
, “A study on the epidemiology of rosacea in the U.K”, Br J Dermatol, vol. 167, pp. 598-605, 2012.
, “A study on the epidemiology of tinnitus in the United Kingdom”, Clin Epidemiol, vol. 11, pp. 855-871, 2019.
, “Tamoxifen and cataracts: a null association”, Breast Cancer Res Treat, vol. 87, pp. 189-96, 2004.
, “Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina”, Cancer, vol. 103, pp. 1114-21, 2005.
, “Trends in incidence and medical resource utilisation in patients with chronic lymphocytic leukaemia: insights from the UK Clinical Practice Research Datalink (CPRD)”, Ann Hematol, vol. 94, pp. 421-9, 2015.
, “Type II diabetes mellitus and incident osteoarthritis of the hand: a population-based case-control analysis”, Osteoarthritis Cartilage, vol. 24, pp. 1535-40, 2016.
, “Urinary tract infections and estrogen use in older women”, J Am Geriatr Soc, vol. 40, pp. 817-20, 1992.
, “Use of acid-suppressive drugs in pregnancy and the risk of childhood asthma: bidirectional crossover study using the general practice research database”, Drug Saf, vol. 36, pp. 1097-104, 2013.
, “Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis”, Am J Gastroenterol, vol. 107, pp. 620-6, 2012.
, “Use of anti-malarial drugs and the risk of developing eye disorders”, Travel Med Infect Dis, vol. 12, pp. 40-7, 2014.
, “Use of beta-blockers and risk of fractures”, Jama, vol. 292, pp. 1326-32, 2004.
, “Use of cardiac glycosides and risk of glioma”, J Neurooncol, vol. 127, pp. 321-8, 2016.
, “Use of depot medroxyprogesterone acetate and fracture risk”, J Clin Endocrinol Metab, vol. 95, pp. 4909-16, 2010.
, “Use of diuretics and risk of incident gout: a population-based case-control study”, Arthritis Rheumatol, vol. 66, pp. 185-96, 2014.
, “Use of metformin and the risk of ovarian cancer: a case-control analysis”, Gynecol Oncol, vol. 123, pp. 200-4, 2011.
, “Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis”, Cancer Epidemiol Biomarkers Prev, vol. 21, pp. 280-6, 2012.
, “Use of Selective Cyclooxygenase-2 Inhibitors, Other Analgesics, and Risk of Glioma”, PLoS One, vol. 11, p. e0149293, 2016.
, “Use of statins and the risk of Parkinson's disease: a retrospective case-control study in the UK”, Drug Saf, vol. 31, pp. 399-407, 2008.
, “Use of thiazolidinediones and fracture risk”, Arch Intern Med, vol. 168, pp. 820-5, 2008.
, “Utilization pattern of hormone therapy in UK general practice between 1996 and 2015: a descriptive study”, Menopause, 2019.
, “Validation of autism spectrum disorder diagnoses recorded in the Clinical Practice Research Datalink, 1990-2014”, Clin Epidemiol, vol. 9, pp. 475-482, 2017.
, “Validation of information recorded on general practitioner based computerised data resource in the United Kingdom”, Bmj, vol. 302, pp. 766-8, 1991.
, “Validation of Stevens-Johnson syndrome or toxic epidermal necrolysis diagnoses in the Clinical Practice Research Datalink”, Pharmacoepidemiol Drug Saf, vol. 26, pp. 429-436, 2017.
, “Validity of the general practice research database”, Pharmacotherapy, vol. 23, pp. 686-9, 2003.
, “Weight change and blood glucose concentration as markers for pancreatic cancer in subjects with new-onset diabetes mellitus: A matched case-control study”, Pancreatology, 2019.
, “Who receives lipid-lowering drugs: the effects of comorbidities and patient characteristics on treatment initiation”, Br J Clin Pharmacol, vol. 55, pp. 288-98, 2003.
,